- Global Pharma News & Resources

Cardiac Pacemaker Devices Market Worth $4,629.3 million by 2022 at a CAGR of 3.3%, Global Industry Analysis to 2022- Meticulous Research®

Meticulous Research – leading global market research company published a research report titled “cardiac pacemaker devices market size by Product (Implantable Cardiac Pacemaker, External Pacemaker, Pacing Leads, and Pacing Analyzer), End-User (Hospitals and Ambulatory Surgery Centers) – Global Forecast to 2022”

According to the latest publication from Meticulous Research®. The global cardiac pacemaker devices market will grow at a CAGR 3.3% from 2017 to 2022 to reach USD 4,629.3 million by 2022, driven by increasing incidence & prevalence of chronic cardiovascular diseases and technological advancements in the area of implantable cardiac pacemakers. In addition, emerging markets and increasing awareness of healthcare further provides a great opportunity for various stakeholders in this market. However, increase in reported cases of cardiac pacemaker malfunctioning & related product recalls restricts the growth of the market to some extent.

Get a free sample copy of the premium report: –

Key Market Segments to Watch

The global cardiac pacemaker devices market is mainly segmented by product, end-user, and geography. On the basis of product, cardiac pacemaker devices market is segmented into cardiac pacemakers, pacing leads, and pacing analyzers. Cardiac pacemaker segment held the largest share of this market, primarily due to rising adoption of cardiac pacing systems for the prevention & better management of sudden cardiac arrest in high-risk patients with cardiovascular disease and the higher price of pacemakers in comparison with pacing leads & analyzers. In addition, increasing incidence of cardiovascular disorders with rising geriatric population, obesity, sedentary lifestyle, unhealthy food; and rising demand for innovative products with technological advancements will further drive the growth of cardiac pacemakers’ market.

Cardiac pacemakers’ market is further sub-segmented into the implantable pacemaker and external pacemaker. Implantable pacemakers are largely used for the prevention of sudden cardiac arrest (SCA) and related deaths in patients at high risk for SCA with increasing incidence of hypertension and atrial fibrillation. In addition, increasing trend of acceptance of modern therapies with growing awareness towards healthcare will further support the growth of this market.

Browse to get more industry insights, table of content and figures : –

On the basis of end-user, cardiac pacemaker devices market is segmented into hospitals, ambulatory surgery centers, and others. Hospitals hold the largest share of this market, mainly due to a large pool of patients visiting hospitals and clinics across the globe for diagnosis & treatment of healthcare concerns including cardiovascular diseases.

Regional Market Growth Trends

By geography, the market is segmented into five major geographies namely: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the major share of the global cardiac pacemaker devices market in 2016, followed by Europe, and Asia-Pacific. The large share of this region is primarily attributed to the increasing incidence of cardiovascular diseases with rising greying population and increasing burden of hypertension; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in this market. However, Asia-Pacific market will outpace the other cardiac pacemaker markets during the forecast period, owing to rising incidence & prevalence of cardiovascular diseases with increasing greying population, increasing the burden of hypertension, growing obesity, and changing lifestyles. In addition, factors such as improving healthcare infrastructure, rising awareness about pacemaker therapy with various government initiatives, increasing healthcare spending, rising affordability of middle-class population, and increasing urbanization are further expected to boost the growth of cardiac pacemaker market in this region.

Top 10 leading companies in cardiac pacemaker devices market are :-

Top Companies in the Cardiac Pacemaker Devices Market

The leading players in the cardiac pacemaker devices market have employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in this market were regulatory approvals, partnerships/collaborations/agreements, new product developments, and expansions. The key players in the global cardiac pacemaker devices market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Lepu Medical Technology Co ltd (China), Medico, S.p.A (Italy), Osypka Medical GmbH (Germany), Shree Pacetronix Ltd (India), and Cook Medical Group (U.S.).

Key questions answered in the report-

Which are the high growth market segments in terms of product, end user, and regions/countries?

What is the historical market for cardiac pacemaker devices market across the globe?

What are the market forecasts and estimates from the period 2015-2022?

What are the major drivers, restraints, opportunities, and trends in the global cardiac pacemaker devices market?

Who are the major players in the global cardiac pacemaker devices market and what share of the market do they hold?

Who are the major players in various countries and what share of the market do they hold?

What are the competitive landscapes and who are the market leaders by sub-region in the global cardiac pacemaker devices market?

What are the recent developments in the global cardiac pacemaker devices market?

What are the different strategies adopted by the major players in the global cardiac pacemaker devices market?

What are the geographical trends and high growth regions/ countries?

Who are the local emerging players in the global cardiac pacemaker devices market and how do they compete with the global players?

Download a free sample report and gain crucial industry insights: –

About Meticulous Research®

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present critical market data with great attention to details.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:

Meticulous Research®


Contact Sales- +1-646-781-8004

Connect with us on LinkedIn-

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 18-Feb-2020